Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Replicel Life Sciences Inc V.RP

Alternate Symbol(s):  REPCF

RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair restoration. RCH-01 is an autologous cell therapy utilizing dermal sheath cup (DSC) cells isolated from the hair follicle to treat androgenetic alopecia. RCS-01 is an autologous cell therapy utilizing non-bulbar dermal sheath (NBDS) cells, a type of fibroblast cell isolated from the hair follicle to repair and regenerate tissue. RCT-01 provides a source of collagen expressing cells to the site of injury, addressing the underlying cause of tendinosis. It has also developed an injection device, DermaPrecise, which improves the administration of its cell therapy products and certain other injectables.


TSXV:RP - Post by User

Comment by bluemoons20on Jul 12, 2023 11:55am
70 Views
Post# 35537552

RE:Has the Arbitration Hearing closed

RE:Has the Arbitration Hearing closedIt  would be nice to have an update relative to this  type of information and the road  forward.  Does not seem to be any breach  to say  that the hearing  ended  on  such date and an answer is expected by  such a date??

Would be nice if there was at least that much information  released.

relative to arbitrations,  depending on the complexity, they  can  wrap  in a few hours or may take a few days for either side to present evidence of  have witnesses appear.  So it is not  always   Go on the day  - submit  your brief  - and say  so long.  There might be an actual hearing which could last a few  hours or  days  and the Arbitrator may have some questions relative to submissions to ensure he/she  understands the issues.  So the  30  days  may not actually  start on  May  29th

With 30  days  for  briefs and  then a further 30   then  July  29th  might be  when  people would hear  unless the  actual hearing went a bit  later.  Certainly  should  be  about  2  to  3 weeks  from  now  if the decision takes the full period to write.

It could even come out  tomorrow    or  Friday??

GLTA

<< Previous
Bullboard Posts
Next >>